GE HealthCare has introduced the SIGNA Sprint, a high-performance 1.5T MRI system, at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025.
SIGNA Sprint aims to enhance imaging capabilities in cardiology, oncology, and various clinical and research fields, offering benefits previously available only on 3.0T systems.
The advanced MRI system is engineered to provide exceptional diffusion imaging, which is crucial for oncology diagnosis and treatment planning.
It is designed to help clinicians and researchers expand the current 1.5T boundaries, facilitating rapid clinical translation and innovative research.
The system’s high-gradient performance of 65/200 per axis ensures fast imaging and outstanding image quality, allowing for detailed visualisation of sub-millimetric structures.
GE HealthCare CEO Kelly Londy said: “We are driven to push the boundaries of what’s possible in MRI with our ultra-premium segment, as our goal is to set a new standard in diagnostic research and precision care that allows for earlier clinical detection and treatment response.
“We are working to enhance diagnostic capabilities to provide highly accurate imaging with peace of mind for patients.
“We hope to help clinicians unlock new horizons for research in advanced imaging.”
GE HealthCare said the SIGNA Sprint supports the shift towards quantitative MRI, offering deeper insights into tissue characteristics beyond basic anatomical assessment.
Deep-learning reconstruction techniques for cardiac MRI are incorporated to reduce interpretation time and improve consistency and reliability.
SIGNA Sprint also prioritises patient comfort with a 70cm wide bore, free-breathing capabilities, and AIR Coils for an enhanced patient experience.
Its built-in AI technologies, such as AIR Recon DL, Sonic DL, and AIR x, aim to deliver high-quality imaging even in challenging anatomies.
Also, the system supports precision care throughout the entire care pathway, from early diagnosis to treatment monitoring.
Furthermore, GE HealthCare plans to present other MRI advancements at ISMRM, including SIGNA MAGNUS, Sonic DL 3D and Freelium.
